Can-fite biopharma ltd. (CANF)
Balance Sheet / Yearly
Jun'18Dec'17Dec'16
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

5,840

3,505

8,115

Other receivable and prepaid expenses

3,286

3,159

2,007

Total current assets

9,126

6,664

10,122

NON-CURRENT ASSETS:
Lease deposits

5

5

10

long-term investment

1,829

917

0

Property, plant and equipment, net

24

28

40

Total long-term assets

1,858

950

50

Total assets

10,984

7,614

10,172

LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables

668

427

1,249

Deferred revenues

792

330

322

Other accounts payable

697

997

933

Warrants exercisable into shares (Series 10-12)

-

-

564

Total current liabilities

2,157

1,754

3,068

NON-CURRENT LIABILITIES:
Deferred revenues

2,317

846

1,143

Total long-term liabilities

2,317

846

1,143

CONTINGENT LIABILITIES AND COMMITMENTS

0

0

0

EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:
Share capital

2,633

2,123

1,783

Share premium

81,646

81,104

79,864

Capital reserve from share-based payment transactions

5,713

5,547

5,167

Warrants exercisable into shares

12,408

8,815

6,947

Treasury shares, at cost

-

-

970

Accumulated other comprehensive income

1,127

1,127

491

Accumulated deficit

-97,017

-93,702

-87,363

Total equity attributable to equity holders of the company

-

-

5,919

Non-controlling interests

-

-

42

Total equity

6,510

5,014

5,961

Total liabilities and equity

10,984

7,614

10,172